{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:10:56Z","timestamp":1763035856502},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1007\/s00115-004-1699-2","type":"journal-article","created":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T10:42:44Z","timestamp":1080816164000},"page":"945-952","source":"Crossref","is-referenced-by-count":8,"title":["Differenzialdiagnose chronisch-entz\u00fcndlicher Erkrankungen des Zentralnervensystems","Cerebrospinal fluid and immunological parameters for differentiation of chronic inflammatory central nervous system disease"],"prefix":"10.1007","volume":"75","author":[{"given":"D.","family":"Reske","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-F.","family":"Petereit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1699_CR1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.57.3.496","volume":"57","author":"Ainiala","year":"2001","unstructured":"Ainiala H, Loukkola J, Peltola J et al. (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57:496\u2013500","journal-title":"Neurology"},{"key":"1699_CR2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0889-857X(21)00211-8","volume":"19","author":"Alexander","year":"1993","unstructured":"Alexander EL (1993) Neurologic disease in Sjogren\u2019s syndrome: mononuclear inflammatory vasculopathy affecting central\/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 19:869\u2013908","journal-title":"Rheum Dis Clin North Am"},{"key":"1699_CR3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1212\/WNL.33.5.593","volume":"33","author":"Alexander","year":"1983","unstructured":"Alexander EL, Alexander GE (1983) Aseptic meningoencephalitis in primary Sjogren\u2019s syndrome. Neurology 33:593\u2013598","journal-title":"Neurology"},{"key":"1699_CR4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7326\/0003-4819-104-3-323","volume":"104","author":"Alexander","year":"1986","unstructured":"Alexander EL, Malinow K, Lejewski JE et al. (1986) Primary Sjogren\u2019s syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 104:323\u2013330","journal-title":"Ann Intern Med"},{"key":"1699_CR5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","volume":"57","author":"Andersson","year":"1994","unstructured":"Andersson M, Alvarez-Cermeno J, Bernardi G et al. (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57:897\u2013902","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1699_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2007-1017570","volume":"27","author":"Berlit","year":"2000","unstructured":"Berlit P (2000) Neurologische Manifestationen von Kollagenosen und Vaskulitiden. Akt Neurol 27:405\u2013411","journal-title":"Akt Neurol"},{"key":"1699_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1055\/s-2002-35855","volume":"70","author":"Berlit","year":"2002","unstructured":"Berlit P, Steinbrecher A (2002) Zerebrale Vaskulitis. Fortschr Neurol Psychiatr 70:663\u2013677","journal-title":"Fortschr Neurol Psychiatr"},{"key":"1699_CR8","doi-asserted-by":"crossref","unstructured":"Bitsch A (2001) Klinische Symptomatik und nat\u00fcrlicher Verlauf der Multiplen Sklerose. In: Zettl UK, Mix E (eds) Multiple Sklerose. Springer, Berlin Heidelberg New York, pp\u00a067\u201376","DOI":"10.1007\/978-3-642-59453-3_6"},{"key":"1699_CR9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archneur.1989.00520390036012","volume":"46","author":"Borucki","year":"1989","unstructured":"Borucki SJ, Nguyen BV, Ladoulis CT et al. (1989) Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis. Arch Neurol 46:270\u2013273","journal-title":"Arch Neurol"},{"key":"1699_CR10","doi-asserted-by":"crossref","unstructured":"Brey RL, Escalante A (1998) Neurological manifestations of antiphospholipid antibody syndrome. Lupus 7(Suppl\u00a02):S67\u2013S74","DOI":"10.1177\/096120339800700216"},{"key":"1699_CR11","first-page":"691","volume":"6","author":"Brook","year":"1979","unstructured":"Brook I, Controni G, Kassan SS et al. (1979) Lactic acid levels in cerebrospinal fluid from patients with systemic lupus erythematosus. J Rheumatol 6:691\u2013693","journal-title":"J Rheumatol"},{"key":"1699_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0895-6111(89)90201-2","volume":"13","author":"Brooks","year":"1989","unstructured":"Brooks ML, Wang AM, Black PM et al. (1989) Subdural mass lesion secondary to sarcoid granuloma MR and CT findings and differential diagnosis. Comput Med Imaging Graph 13:199-205","journal-title":"Comput Med Imaging Graph"},{"key":"1699_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.245.1.62","volume":"245","author":"Cariski","year":"1981","unstructured":"Cariski AT (1981) Isolated CNS sarcoidosis. JAMA 245:62\u201363","journal-title":"JAMA"},{"key":"1699_CR14","first-page":"99","volume":"26","author":"Chen","year":"1989","unstructured":"Chen RC, McLeod JG (1989) Neurological complications of sarcoidosis. Clin Exp Neurol 26:99\u2013112","journal-title":"Clin Exp Neurol"},{"key":"1699_CR15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/0003-4819-87-3-336","volume":"87","author":"Delaney","year":"1977","unstructured":"Delaney P (1977) Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 87:336\u2013345","journal-title":"Ann Intern Med"},{"key":"1699_CR16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/jnnp.48.8.807","volume":"48","author":"Ernerudh","year":"1983","unstructured":"Ernerudh J, Olsson T, Lindstrom F et al. (1983) Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 48:807\u2013813","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1699_CR17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00005792-197607000-00004","volume":"55","author":"Feinglass","year":"1976","unstructured":"Feinglass EJ, Arnett FC, Dorsch CA et al. (1976) Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine 55:323\u2013339","journal-title":"Medicine"},{"key":"1699_CR18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/ard.35.5.398","volume":"35","author":"Gibson","year":"1975","unstructured":"Gibson T, Myers AR (1975) Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis 35:398\u2013406","journal-title":"Ann Rheum Dis"},{"key":"1699_CR19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1259\/0007-1285-69-819-272","volume":"69","author":"Grand","year":"1996","unstructured":"Grand S, Hoffmann D, Bost F et al. (1996) Case report: pseudotumoral brain lesion as the presenting feature of sarcoidosis. Br J Radiol 69: 272\u2013275","journal-title":"Br J Radiol"},{"key":"1699_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.37.2.121","volume":"37","author":"Grigor","year":"1978","unstructured":"Grigor R, Edmonds J, Lewkonia R et al. (1978) Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis 37:121\u2013128","journal-title":"Ann Rheum Dis"},{"key":"1699_CR21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0733-8619(03)00054-9","volume":"20","author":"Gullapalli","year":"2002","unstructured":"Gullapalli D, Phillips LH 2nd (2002) Neurologic manifestations of sarcoidosis. Neurol Clin 20:59\u201383","journal-title":"Neurol Clin"},{"key":"1699_CR22","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/art.1780400825","volume":"40","author":"Hanly","year":"1997","unstructured":"Hanly JG, Cassell K, Fisk JD (1997) Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 40:1542\u20131543","journal-title":"Arthritis Rheum"},{"key":"1699_CR23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-0404.1990.tb00951.x","volume":"81","author":"Hietaharju","year":"1990","unstructured":"Hietaharju A, Yli-Kerttula U, Hakkinen V et al. (1990) Nervous system manifestations in Sjogren\u2019s syndrome. Acta Neurol Scand 81:144-152","journal-title":"Acta Neurol Scand"},{"key":"1699_CR24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0404.1993.tb04241.x","volume":"88","author":"Hietaharju","year":"1993","unstructured":"Hietaharju A, Jantti V, Korpela M et al. (1993) Nervous system involvement in systemic lupus erythematosus, Sjogren syndrome and scleroderma. Acta Neurol Scand 88:299\u2013308","journal-title":"Acta Neurol Scand"},{"key":"1699_CR25","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1001\/archinte.145.10.1843","volume":"145","author":"Hirohata","year":"1985","unstructured":"Hirohata S, Hirose S, Miyamoto T (1985) Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity. Arch Intern Med 145:1843\u20131846","journal-title":"Arch Intern Med"},{"key":"1699_CR26","first-page":"1078","volume":"335","author":"International","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"1699_CR27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/rheumatology\/41.6.605","volume":"41","author":"Jennekens","year":"1999","unstructured":"Jennekens FGI, Kater L (1999) The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology 41:605\u2013618","journal-title":"Rheumatology"},{"key":"1699_CR28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/jnnp.66.4.510","volume":"66","author":"Larner","year":"1999","unstructured":"Larner AJ, Ball JA, Howard RS (1999) Sarcoid tumour: continuing diagnostic problems in the MRI era. J Neurol Neurosurg Psychiatry 66:510\u2013512","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1699_CR29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1212\/WNL.41.5.657","volume":"41","author":"Lee","year":"1991","unstructured":"Lee KH, Hashimoto SA, Hooge JP et al. (1991) Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 41:657\u2013660","journal-title":"Neurology"},{"key":"1699_CR30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0404.1990.tb01578.x","volume":"82","author":"Losy","year":"1990","unstructured":"Losy J, Mehta PD, Wisniewski HM (1990) Identification of IgG subclasses\u2019 oligoclonal bands in multiple sclerosis CSF. Acta Neurol Scand 82:4-8","journal-title":"Acta Neurol Scand"},{"key":"1699_CR31","first-page":"211","volume":"2","author":"Lowenthal","year":"1994","unstructured":"Lowenthal A, Karcher D (1994) Cerebrospinal fluid in multiple sclerosis. Clin Neurosci 2:211\u2013214","journal-title":"Clin Neurosci"},{"key":"1699_CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0033-8389(05)70079-8","volume":"37","author":"Mafee","year":"1999","unstructured":"Mafee MF, Dorodi S, Pai E (1999) Sarcoidosis of the eye, orbit, and central nervous system. Role of MR imaging. Radiol Clin North Am 37:73\u201387","journal-title":"Radiol Clin North Am"},{"key":"1699_CR33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-103-3-344","volume":"103","author":"Malinow","year":"1985","unstructured":"Malinow KL, Molina R, Gordon B et al. (1985) Neuropsychiatric dysfunction in primary Sjogren\u2019s syndrome. Ann Intern Med 103:344\u2013350","journal-title":"Ann Intern Med"},{"key":"1699_CR34","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3171\/jns.1993.78.6.0994","volume":"78","author":"Mayer","year":"1993","unstructured":"Mayer SA, Yim GK, Onesti ST et al. (1993) Biopsy-proven isolated sarcoid meningitis. Case report. J Neurosurg 78:994\u2013996","journal-title":"J Neurosurg"},{"key":"1699_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121\u2013127","journal-title":"Ann Neurol"},{"key":"1699_CR36","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jnnp.58.5.548","volume":"58","author":"McLean","year":"1995","unstructured":"McLean BN, Miller D, Thompson EJ (1995) Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet\u2019s disease involving the nervous system. J Neurol Neurosurg Psychiatry 58:548\u2013554","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1699_CR37","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","volume":"336","author":"Newman","year":"1997","unstructured":"Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224\u20131234","journal-title":"N Engl J Med"},{"key":"1699_CR38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0049-0172(99)80033-X","volume":"29","author":"Niemela","year":"1999","unstructured":"Niemela RK, Hakala M (1999) Primary Sjogren\u2019s syndrome with severe central nervous system disease. Semin Arthritis Rheum 29:4-13","journal-title":"Semin Arthritis Rheum"},{"key":"1699_CR39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1600-0404.1986.tb03277.x","volume":"73","author":"Oksanen","year":"1986","unstructured":"Oksanen V (1986) Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurol Scand 73:283\u2013290","journal-title":"Acta Neurol Scand"},{"key":"1699_CR40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0404.1982.tb06856.x","volume":"66","author":"Poser","year":"1982","unstructured":"Poser CM, Raun NE, Poser W (1982) Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol Scand 66:355\u2013362","journal-title":"Acta Neurol Scand"},{"key":"1699_CR41","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/clinchem\/37.7.1153","volume":"37","author":"Reiber","year":"1991","unstructured":"Reiber H, Lange P (1991) Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 37:1153\u20131160","journal-title":"Clin Chem"},{"key":"1699_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1191\/135245898678909448","volume":"4","author":"Reiber","year":"1998","unstructured":"Reiber H, Ungefehr S, Jacobi C (1998) The intrathecal and oligoclonal immune response in multiple sclerosis. Mult Scler 4:111\u2013117","journal-title":"Mult Scler"},{"key":"1699_CR43","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/ajcp\/19.8.725","volume":"1119","author":"Ricker","year":"1949","unstructured":"Ricker W, Clark M (1949) Sarcoidosis: a clinical pathologic review of 300 cases. Am J Clin Pathol 1119:725\u201349","journal-title":"Am J Clin Pathol"},{"key":"1699_CR44","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/WNL.46.2.368","volume":"46","author":"Rolak","year":"1996","unstructured":"Rolak LA, Beck RW, Paty DW et al. (1996) Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. Neurology 46:368\u2013372","journal-title":"Neurology"},{"key":"1699_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0165-5728(98)00174-X","volume":"93","author":"Rudick","year":"1999","unstructured":"Rudick RA, Cookfair DL, Simonian NA et al (1999) Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFN\u03b2-1a) for relapsing multiple sclerosis. The Multiple Sclerosis collaborative research group. J Neuroimmunol 93:8\u201314","journal-title":"J Neuroimmunol"},{"key":"1699_CR46","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0002-9343(88)90082-4","volume":"84","author":"Scott","year":"1988","unstructured":"Scott TF (1988) A new cause of cerebrospinal fluid eosinophilia: neurosarcoidosis. Am J Med 84:973\u2013974","journal-title":"Am J Med"},{"key":"1699_CR47","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1212\/WNL.39.12.1637","volume":"39","author":"Scott","year":"1989","unstructured":"Scott TF, Seay AR, Goust JM (1989) Pattern and concentration of IgG in cerebrospinal fluid in neurosarcoidosis. Neurology 39:1637\u20131639","journal-title":"Neurology"},{"key":"1699_CR48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archneur.1989.00520390031011","volume":"46","author":"Serdaroglu","year":"1989","unstructured":"Serdaroglu P, Yazici H, Ozdemir C et al. (1989) Neurologic involvement in Behcet\u2019s syndrome. A prospective study. Arch Neurol 46:265\u2013269","journal-title":"Arch Neurol"},{"key":"1699_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0022-510X(90)90126-8","volume":"96","author":"Sharief","year":"1990","unstructured":"Sharief MK, Keir G, Thompson EJ (1990) Intrathecal synthesis of IgM in neurological diseases: a comparison between detection of oligoclonal bands and quantitative estimation. J Neurol Sci 96:131\u2013142","journal-title":"J Neurol Sci"},{"key":"1699_CR50","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1212\/WNL.41.9.1398","volume":"41","author":"Sharief","year":"1991","unstructured":"Sharief MK, Hentges R, Thomas E (1991) Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behcet\u2019s disease. Neurology 41:1398\u20131401","journal-title":"Neurology"},{"key":"1699_CR51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1378\/chest.112.1.220","volume":"112","author":"Sharma","year":"1997","unstructured":"Sharma OP (1997) Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 112:220\u2013228","journal-title":"Chest"},{"key":"1699_CR52","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0022-510X(82)90131-9","volume":"55","author":"Sindic","year":"1982","unstructured":"Sindic CJ, Cambiaso CL, Depre A et al. (1982) The concentration of IgM in the cerebrospinal fluid of neurological patients. J Neurol Sci 55:339\u2013350","journal-title":"J Neurol Sci"},{"key":"1699_CR53","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s004150170154","volume":"248","author":"Siva","year":"2001","unstructured":"Siva A (2001) Vasculitis of the nervous system. J Neurol 248:451\u2013468","journal-title":"J Neurol"},{"key":"1699_CR54","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.50.3.708","volume":"50","author":"Soderstrom","year":"1998","unstructured":"Soderstrom M, Ya-Ping J, Hillert J et al. (1998) Optic neuritis: prognostis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 50:708\u2013714","journal-title":"Neurology"},{"key":"1699_CR55","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF02279763","volume":"240","author":"Sommer","year":"1991","unstructured":"Sommer N, Weller M, Petersen D et al. (1991) Neurosarcoidosis without systemic sarcoidosis. Eur Arch Psychiatry Clin Neurosci 240:334\u2013338","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1699_CR56","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archneur.1985.04060080095022","volume":"42","author":"Stern","year":"1985","unstructured":"Stern BJ, Krumholz A, Johns C et al. (1985) Sarcoidosis and its neurological manifestations. Arch Neurol 42:909\u2013917","journal-title":"Arch Neurol"},{"key":"1699_CR57","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.37.5.878","volume":"37","author":"Stern","year":"1987","unstructured":"Stern BJ, Griffin DE, Luke RA et al. (1987) Neurosarcoidosis: cerebrospinal fluid lymphocyte subpopulations. Neurology 37:878\u2013881","journal-title":"Neurology"},{"key":"1699_CR58","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/1531-8249(200006)47:6<831::AID-ANA21>3.3.CO;2-8","volume":"47","author":"Thompson","year":"2000","unstructured":"Thompson AJ, Montalban X, Barkhof F et al. (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831\u2013835","journal-title":"Ann Neurol"},{"key":"1699_CR59","unstructured":"Tourtellotte WW (1985) The cerebrospinal fluid in multiple sclerosis. In: Bruyn G (ed) Handbook of clinical neurology, vol\u00a03(47). Elsevier, Amsterdam, pp\u00a079\u2013130"},{"key":"1699_CR60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.26.6_Part_2.59","volume":"26","author":"Tourtellotte","year":"1976","unstructured":"Tourtellotte WW, Murthy K, Brandes D et al. (1976) Schemes to eradicate the multiple sclerosis central nervous system immune reaction. Neurology 26:59\u201361","journal-title":"Neurology"},{"key":"1699_CR61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-3083.1976.tb00297.x","volume":"5","author":"Vandvik","year":"1976","unstructured":"Vandvik B, Natvig JB, Wiger D (1976) IgG1 subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitides. Scand J Immunol 5:427\u2013436","journal-title":"Scand J Immunol"},{"key":"1699_CR62","first-page":"641","volume":"54","author":"Vartdal","year":"1983","unstructured":"Vartdal F, Vandvik B (1983) Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies. Clin Exp Immunol 54:641\u2013647","journal-title":"Clin Exp Immunol"},{"key":"1699_CR63","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0022-510X(90)90032-I","volume":"100","author":"Vrethem","year":"1990","unstructured":"Vrethem M, Ernerudh J, Lindstrom F et al. (1990) Immunoglobulins within the central nervous system in primary Sjogren\u201as syndrome. J Neurol Sci 100:186\u2013192","journal-title":"J Neurol Sci"},{"key":"1699_CR64","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(83)91075-6","volume":"74","author":"Winfield","year":"1983","unstructured":"Winfield JB, Shaw M, Silverman LM et al. (1983) Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 74:837\u2013844","journal-title":"Am J Med"},{"key":"1699_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/qjmed\/92.2.103","volume":"92","author":"Zajicek","year":"1999","unstructured":"Zajicek JP, Scolding NJ, Foster O et al. (1999) Central nervous system sarcoidosis-diagnosis and management. QJM 92:103\u201317","journal-title":"QJM"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-004-1699-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-004-1699-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-004-1699-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-004-1699-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T09:28:43Z","timestamp":1699349323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-004-1699-2"}},"subtitle":["Liquordiagnostik und immunologische Parameter"],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["1699"],"URL":"https:\/\/doi.org\/10.1007\/s00115-004-1699-2","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}